243 related articles for article (PubMed ID: 29192323)
1. Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.
Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
Oncol Rep; 2018 Jan; 39(1):109-118. PubMed ID: 29192323
[TBL] [Abstract][Full Text] [Related]
2. Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth.
Guo X; Zhu X; Liu D; Gong Y; Sun J; Dong C
Int J Nanomedicine; 2017; 12():6923-6936. PubMed ID: 29075111
[TBL] [Abstract][Full Text] [Related]
3. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres.
Guo X; Dong C; Liu Q; Zhu X; Zuo S; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108823. PubMed ID: 30965238
[TBL] [Abstract][Full Text] [Related]
4. Promotion of Propranolol Delivery to Hemangiomas by Using Anti-VEGFR Antibody-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles.
Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
J Biomed Nanotechnol; 2017 Dec; 13(12):1694-1705. PubMed ID: 29490757
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hemangioma growth using polymer-lipid hybrid nanoparticles for delivery of rapamycin.
Li H; Teng Y; Sun J; Liu J
Biomed Pharmacother; 2017 Nov; 95():875-884. PubMed ID: 28903183
[TBL] [Abstract][Full Text] [Related]
6. Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway.
Sun B; Dong C; Lei H; Gong Y; Li M; Zhang Y; Zhang H; Sun L
Chem Biol Interact; 2018 Oct; 294():28-33. PubMed ID: 30130526
[TBL] [Abstract][Full Text] [Related]
7. PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma.
Guo X; Zhu X; Gao J; Liu D; Dong C; Jin X
Nanomedicine (Lond); 2017 Nov; 12(21):2611-2624. PubMed ID: 28960167
[TBL] [Abstract][Full Text] [Related]
8. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Pan WK; Li P; Guo ZT; Huang Q; Gao Y
Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
[TBL] [Abstract][Full Text] [Related]
9. Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway.
Yao TH; Pataer P; Regmi KP; Gu XW; Li QY; Du JT; Ge SM; Tu JB
Mol Med Rep; 2018 Jul; 18(1):684-694. PubMed ID: 29767244
[TBL] [Abstract][Full Text] [Related]
10. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
[TBL] [Abstract][Full Text] [Related]
11. β-elemene affects angiogenesis of infantile hemangioma by regulating angiotensin-converting enzyme 2 and hypoxia-inducible factor-1 alpha.
Wang Z; Wang Z; Du C; Zhang Y; Tao B; Xian H
J Nat Med; 2021 Jun; 75(3):655-663. PubMed ID: 33861415
[TBL] [Abstract][Full Text] [Related]
12. Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells.
Ji Y; Li K; Xiao X; Zheng S; Xu T; Chen S
J Pediatr Surg; 2012 Dec; 47(12):2216-23. PubMed ID: 23217879
[TBL] [Abstract][Full Text] [Related]
13. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor.
Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T
Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797
[TBL] [Abstract][Full Text] [Related]
14. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
[TBL] [Abstract][Full Text] [Related]
15. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
18. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
Huang L; Nakayama H; Klagsbrun M; Mulliken JB; Bischoff J
Stem Cells; 2015 Jan; 33(1):133-45. PubMed ID: 25187207
[TBL] [Abstract][Full Text] [Related]
19. Propranolol inhibits proliferation and induces apoptosis of hemangioma-derived endothelial cells via Akt pathway by down-regulating Ang-2 expression.
Sun B; Dong C; Lei H; Gong Y; Li M; Zhang Y; Zhang H; Sun L
Chem Biol Interact; 2020 Jan; 316():108925. PubMed ID: 31838054
[TBL] [Abstract][Full Text] [Related]
20. Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.
Chen Q; Ying H; Yu Z; Chang L; Chen Z; Chen J; Chang SJ; Qiu Y; Lin X
J Invest Dermatol; 2023 Apr; 143(4):566-577.e12. PubMed ID: 36243122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
